Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 144

1.

Striatal Glutathione in First-episode Psychosis Patients Measured In Vivo with Proton Magnetic Resonance Spectroscopy.

Reyes-Madrigal F, León-Ortiz P, Mao X, Mora-Durán R, Shungu DC, de la Fuente-Sandoval C.

Arch Med Res. 2019 May;50(4):207-213. doi: 10.1016/j.arcmed.2019.08.003. Epub 2019 Sep 26.

PMID:
31499481
2.

Effects of acute N-acetylcysteine challenge on cortical glutathione and glutamate in schizophrenia: A pilot in vivo proton magnetic resonance spectroscopy study.

Girgis RR, Baker S, Mao X, Gil R, Javitt DC, Kantrowitz JT, Gu M, Spielman DM, Ojeil N, Xu X, Abi-Dargham A, Shungu DC, Kegeles LS.

Psychiatry Res. 2019 May;275:78-85. doi: 10.1016/j.psychres.2019.03.018. Epub 2019 Mar 12.

PMID:
30884334
3.

Magnetic Resonance Spectroscopy, Positron Emission Tomography and Radiogenomics-Relevance to Glioma.

Chiang GC, Kovanlikaya I, Choi C, Ramakrishna R, Magge R, Shungu DC.

Front Neurol. 2018 Feb 5;9:33. doi: 10.3389/fneur.2018.00033. eCollection 2018. Review.

4.

A pilot study of minocycline for the treatment of bipolar depression: Effects on cortical glutathione and oxidative stress in vivo.

Murrough JW, Huryk KM, Mao X, Iacoviello B, Collins K, Nierenberg AA, Kang G, Shungu DC, Iosifescu DV.

J Affect Disord. 2018 Apr 1;230:56-64. doi: 10.1016/j.jad.2017.12.067. Epub 2018 Jan 2.

PMID:
29407539
5.

Long-range gamma phase synchronization as a compensatory strategy during working memory in high-performing patients with schizophrenia.

So RP, Kegeles LS, Mao X, Shungu DC, Stanford AD, Chen CA.

J Clin Exp Neuropsychol. 2018 Sep;40(7):663-681. doi: 10.1080/13803395.2017.1420142. Epub 2018 Feb 1.

PMID:
29388507
6.

Elevations of Ventricular Lactate Levels Occur in Both Chronic Fatigue Syndrome and Fibromyalgia.

Natelson BH, Vu D, Coplan JD, Mao X, Blate M, Kang G, Soto E, Kapusuz T, Shungu DC.

Fatigue. 2017;5(1):15-20. doi: 10.1080/21641846.2017.1280114. Epub 2017 Feb 20.

7.

Prefrontal and Striatal Gamma-Aminobutyric Acid Levels and the Effect of Antipsychotic Treatment in First-Episode Psychosis Patients.

de la Fuente-Sandoval C, Reyes-Madrigal F, Mao X, León-Ortiz P, Rodríguez-Mayoral O, Jung-Cook H, Solís-Vivanco R, Graff-Guerrero A, Shungu DC.

Biol Psychiatry. 2018 Mar 15;83(6):475-483. doi: 10.1016/j.biopsych.2017.09.028. Epub 2017 Oct 10.

8.

A pilot study of cortical glutathione in youth with depression.

Freed RD, Hollenhorst CN, Weiduschat N, Mao X, Kang G, Shungu DC, Gabbay V.

Psychiatry Res Neuroimaging. 2017 Dec 30;270:54-60. doi: 10.1016/j.pscychresns.2017.10.001. Epub 2017 Oct 2.

9.

Anterior cingulate cortex γ-aminobutyric acid deficits in youth with depression.

Gabbay V, Bradley KA, Mao X, Ostrover R, Kang G, Shungu DC.

Transl Psychiatry. 2017 Aug 22;7(8):e1216. doi: 10.1038/tp.2017.187.

10.

Dorsolateral prefrontal cortex GABA deficit in older adults with sleep-disordered breathing.

Pereira AC, Mao X, Jiang CS, Kang G, Milrad S, McEwen BS, Krieger AC, Shungu DC.

Proc Natl Acad Sci U S A. 2017 Sep 19;114(38):10250-10255. doi: 10.1073/pnas.1700177114. Epub 2017 Sep 5. Erratum in: Proc Natl Acad Sci U S A. 2017 Oct 23;:.

11.

Relationships among Cortical Glutathione Levels, Brain Amyloidosis, and Memory in Healthy Older Adults Investigated In Vivo with 1H-MRS and Pittsburgh Compound-B PET.

Chiang GC, Mao X, Kang G, Chang E, Pandya S, Vallabhajosula S, Isaacson R, Ravdin LD; Alzheimer's Disease Neuroimaging Initiative, Shungu DC.

AJNR Am J Neuroradiol. 2017 Jun;38(6):1130-1137. doi: 10.3174/ajnr.A5143. Epub 2017 Mar 24.

12.

Multimodal and simultaneous assessments of brain and spinal fluid abnormalities in chronic fatigue syndrome and the effects of psychiatric comorbidity.

Natelson BH, Mao X, Stegner AJ, Lange G, Vu D, Blate M, Kang G, Soto E, Kapusuz T, Shungu DC.

J Neurol Sci. 2017 Apr 15;375:411-416. doi: 10.1016/j.jns.2017.02.046. Epub 2017 Feb 22.

13.

The Nucleus Accumbens and Ketamine Treatment in Major Depressive Disorder.

Abdallah CG, Jackowski A, Salas R, Gupta S, Sato JR, Mao X, Coplan JD, Shungu DC, Mathew SJ.

Neuropsychopharmacology. 2017 Jul;42(8):1739-1746. doi: 10.1038/npp.2017.49. Epub 2017 Mar 8.

14.

d-Cycloserine, an NMDA Glutamate Receptor Glycine Site Partial Agonist, Induces Acute Increases in Brain Glutamate Plus Glutamine and GABA Comparable to Ketamine.

Kantrowitz JT, Milak MS, Mao X, Shungu DC, Mann JJ.

Am J Psychiatry. 2016 Dec 1;173(12):1241-1242. No abstract available.

PMID:
27903101
15.

Decreased Anterior Cingulate Cortex γ-Aminobutyric Acid in Youth With Tourette's Disorder.

Freed RD, Coffey BJ, Mao X, Weiduschat N, Kang G, Shungu DC, Gabbay V.

Pediatr Neurol. 2016 Dec;65:64-70. doi: 10.1016/j.pediatrneurol.2016.08.017. Epub 2016 Sep 12.

PMID:
27743746
16.

Brain γ-aminobutyric acid (GABA) detection in vivo with the J-editing (1) H MRS technique: a comprehensive methodological evaluation of sensitivity enhancement, macromolecule contamination and test-retest reliability.

Shungu DC, Mao X, Gonzales R, Soones TN, Dyke JP, van der Veen JW, Kegeles LS.

NMR Biomed. 2016 Jul;29(7):932-42. doi: 10.1002/nbm.3539. Epub 2016 May 13.

17.

Elevated prefrontal cortex GABA in patients with major depressive disorder after TMS treatment measured with proton magnetic resonance spectroscopy.

Dubin MJ, Mao X, Banerjee S, Goodman Z, Lapidus KA, Kang G, Liston C, Shungu DC.

J Psychiatry Neurosci. 2016 Apr;41(3):E37-45.

18.

Increased ventricular cerebrospinal fluid lactate in depressed adolescents.

Bradley KA, Mao X, Case JA, Kang G, Shungu DC, Gabbay V.

Eur Psychiatry. 2016 Feb;32:1-8. doi: 10.1016/j.eurpsy.2015.08.009. Epub 2016 Jan 21.

19.

Impact of childhood emotional abuse on neocortical neurometabolites and complex emotional processing in patients with generalized anxiety disorder.

Raparia E, Coplan JD, Abdallah CG, Hof PR, Mao X, Mathew SJ, Shungu DC.

J Affect Disord. 2016 Jan 15;190:414-423. doi: 10.1016/j.jad.2015.09.019. Epub 2015 Oct 23.

PMID:
26551399
20.

Cortico-Striatal GABAergic and Glutamatergic Dysregulations in Subjects at Ultra-High Risk for Psychosis Investigated with Proton Magnetic Resonance Spectroscopy.

de la Fuente-Sandoval C, Reyes-Madrigal F, Mao X, León-Ortiz P, Rodríguez-Mayoral O, Solís-Vivanco R, Favila R, Graff-Guerrero A, Shungu DC.

Int J Neuropsychopharmacol. 2015 Sep 12;19(3):pyv105. doi: 10.1093/ijnp/pyv105.

21.

Effect of Milnacipran Treatment on Ventricular Lactate in Fibromyalgia: A Randomized, Double-Blind, Placebo-Controlled Trial.

Natelson BH, Vu D, Mao X, Weiduschat N, Togo F, Lange G, Blate M, Kang G, Coplan JD, Shungu DC.

J Pain. 2015 Nov;16(11):1211-9. doi: 10.1016/j.jpain.2015.08.004. Epub 2015 Aug 31.

22.

A pilot in vivo proton magnetic resonance spectroscopy study of amino acid neurotransmitter response to ketamine treatment of major depressive disorder.

Milak MS, Proper CJ, Mulhern ST, Parter AL, Kegeles LS, Ogden RT, Mao X, Rodriguez CI, Oquendo MA, Suckow RF, Cooper TB, Keilp JG, Shungu DC, Mann JJ.

Mol Psychiatry. 2016 Mar;21(3):320-7. doi: 10.1038/mp.2015.83. Epub 2015 Aug 18.

23.

In vivo effects of ketamine on glutamate-glutamine and gamma-aminobutyric acid in obsessive-compulsive disorder: Proof of concept.

Rodriguez CI, Kegeles LS, Levinson A, Ogden RT, Mao X, Milak MS, Vermes D, Xie S, Hunter L, Flood P, Moore H, Shungu DC, Simpson HB.

Psychiatry Res. 2015 Aug 30;233(2):141-7. doi: 10.1016/j.pscychresns.2015.06.001. Epub 2015 Jun 6.

24.

Prefrontal cortical GABA abnormalities are associated with reduced hippocampal volume in major depressive disorder.

Abdallah CG, Jackowski A, Sato JR, Mao X, Kang G, Cheema R, Coplan JD, Mathew SJ, Shungu DC.

Eur Neuropsychopharmacol. 2015 Aug;25(8):1082-90. doi: 10.1016/j.euroneuro.2015.04.025. Epub 2015 May 5.

25.

Assessment of glutamate in striatal subregions in obsessive-compulsive disorder with proton magnetic resonance spectroscopy.

Simpson HB, Kegeles LS, Hunter L, Mao X, Van Meter P, Xu X, Kimeldorf MB, Pearlstein SL, Slifstein M, Shungu DC.

Psychiatry Res. 2015 Apr 30;232(1):65-70. doi: 10.1016/j.pscychresns.2015.01.009. Epub 2015 Feb 3.

26.

Motor cortex glutathione deficit in ALS measured in vivo with the J-editing technique.

Weiduschat N, Mao X, Hupf J, Armstrong N, Kang G, Lange DJ, Mitsumoto H, Shungu DC.

Neurosci Lett. 2014 Jun 6;570:102-7. doi: 10.1016/j.neulet.2014.04.020. Epub 2014 Apr 24.

PMID:
24769125
27.

GABA level, gamma oscillation, and working memory performance in schizophrenia.

Chen CM, Stanford AD, Mao X, Abi-Dargham A, Shungu DC, Lisanby SH, Schroeder CE, Kegeles LS.

Neuroimage Clin. 2014 Mar 20;4:531-9. doi: 10.1016/j.nicl.2014.03.007. eCollection 2014.

28.

In vivo (1)H MRS study of potential associations between glutathione, oxidative stress and anhedonia in major depressive disorder.

Lapidus KA, Gabbay V, Mao X, Johnson A, Murrough JW, Mathew SJ, Shungu DC.

Neurosci Lett. 2014 May 21;569:74-9. doi: 10.1016/j.neulet.2014.03.056. Epub 2014 Apr 2.

29.

Sex differences in cerebral energy metabolism in Parkinson's disease: a phosphorus magnetic resonance spectroscopic imaging study.

Weiduschat N, Mao X, Beal MF, Nirenberg MJ, Shungu DC, Henchcliffe C.

Parkinsonism Relat Disord. 2014 May;20(5):545-8. doi: 10.1016/j.parkreldis.2014.02.003. Epub 2014 Feb 13.

PMID:
24593902
30.

Reduced hippocampal N-acetyl-aspartate (NAA) as a biomarker for overweight.

Coplan JD, Fathy HM, Abdallah CG, Ragab SA, Kral JG, Mao X, Shungu DC, Mathew SJ.

Neuroimage Clin. 2014 Jan 9;4:326-35. doi: 10.1016/j.nicl.2013.12.014. eCollection 2014.

31.

Cerebral metabolic abnormalities in A3243G mitochondrial DNA mutation carriers.

Weiduschat N, Kaufmann P, Mao X, Engelstad KM, Hinton V, DiMauro S, De Vivo D, Shungu D.

Neurology. 2014 Mar 4;82(9):798-805. doi: 10.1212/WNL.0000000000000169. Epub 2014 Jan 29.

32.

Usefulness of proton and phosphorus MR spectroscopic imaging for early diagnosis of Parkinson's disease.

Weiduschat N, Mao X, Beal MF, Nirenberg MJ, Shungu DC, Henchcliffe C.

J Neuroimaging. 2015 Jan-Feb;25(1):105-10. doi: 10.1111/jon.12074. Epub 2013 Dec 10.

PMID:
24325203
33.

Imaging glutamate homeostasis in cocaine addiction with the metabotropic glutamate receptor 5 positron emission tomography radiotracer [(11)C]ABP688 and magnetic resonance spectroscopy.

Martinez D, Slifstein M, Nabulsi N, Grassetti A, Urban NB, Perez A, Liu F, Lin SF, Ropchan J, Mao X, Kegeles LS, Shungu DC, Carson RE, Huang Y.

Biol Psychiatry. 2014 Jan 15;75(2):165-71. doi: 10.1016/j.biopsych.2013.06.026. Epub 2013 Sep 12.

34.

Riluzole effect on occipital cortex: a structural and spectroscopy pilot study.

Abdallah CG, Coplan JD, Jackowski A, Sato JR, Mao X, Shungu DC, Mathew SJ.

Neurosci Lett. 2012 Nov 14;530(1):103-7. doi: 10.1016/j.neulet.2012.09.054. Epub 2012 Oct 5.

35.

Assessment of disease severity in late infantile neuronal ceroid lipofuscinosis using multiparametric MR imaging.

Dyke JP, Sondhi D, Voss HU, Shungu DC, Mao X, Yohay K, Worgall S, Hackett NR, Hollmann C, Yeotsas ME, Jeong AL, Van de Graaf B, Cao I, Kaminsky SM, Heier LA, Rudser KD, Souweidane MM, Kaplitt MG, Kosofsky B, Crystal RG, Ballon D.

AJNR Am J Neuroradiol. 2013 Apr;34(4):884-9. doi: 10.3174/ajnr.A3297. Epub 2012 Oct 4.

36.

Investigation of cortical glutamate-glutamine and γ-aminobutyric acid in obsessive-compulsive disorder by proton magnetic resonance spectroscopy.

Simpson HB, Shungu DC, Bender J Jr, Mao X, Xu X, Slifstein M, Kegeles LS.

Neuropsychopharmacology. 2012 Nov;37(12):2684-92. doi: 10.1038/npp.2012.132. Epub 2012 Aug 1.

37.

A pilot study of hippocampal volume and N-acetylaspartate (NAA) as response biomarkers in riluzole-treated patients with GAD.

Abdallah CG, Coplan JD, Jackowski A, Sato JR, Mao X, Shungu DC, Mathew SJ.

Eur Neuropsychopharmacol. 2013 Apr;23(4):276-84. doi: 10.1016/j.euroneuro.2012.05.009. Epub 2012 Jun 26.

38.

N-acetylcysteine for the treatment of glutathione deficiency and oxidative stress in schizophrenia.

Shungu DC.

Biol Psychiatry. 2012 Jun 1;71(11):937-8. doi: 10.1016/j.biopsych.2012.03.025. No abstract available.

PMID:
22579304
39.

Metabolic response of glioblastoma to superselective intra-arterial cerebral infusion of bevacizumab: a proton MR spectroscopic imaging study.

Jeon JY, Kovanlikaya I, Boockvar JA, Mao X, Shin B, K Burkhardt J, Kesavabhotla K, Christos P, Riina H, Shungu DC, Tsiouris AJ.

AJNR Am J Neuroradiol. 2012 Dec;33(11):2095-102. doi: 10.3174/ajnr.A3091. Epub 2012 May 10.

40.

The Relationship between Intelligence and Anxiety: An Association with Subcortical White Matter Metabolism.

Coplan JD, Hodulik S, Mathew SJ, Mao X, Hof PR, Gorman JM, Shungu DC.

Front Evol Neurosci. 2012 Feb 1;3:8. doi: 10.3389/fnevo.2011.00008. eCollection 2011.

41.

Increased ventricular lactate in chronic fatigue syndrome. III. Relationships to cortical glutathione and clinical symptoms implicate oxidative stress in disorder pathophysiology.

Shungu DC, Weiduschat N, Murrough JW, Mao X, Pillemer S, Dyke JP, Medow MS, Natelson BH, Stewart JM, Mathew SJ.

NMR Biomed. 2012 Sep;25(9):1073-87. doi: 10.1002/nbm.2772. Epub 2012 Jan 27.

42.

Elevated prefrontal cortex γ-aminobutyric acid and glutamate-glutamine levels in schizophrenia measured in vivo with proton magnetic resonance spectroscopy.

Kegeles LS, Mao X, Stanford AD, Girgis R, Ojeil N, Xu X, Gil R, Slifstein M, Abi-Dargham A, Lisanby SH, Shungu DC.

Arch Gen Psychiatry. 2012 May;69(5):449-59. doi: 10.1001/archgenpsychiatry.2011.1519. Epub 2012 Jan 2.

PMID:
22213769
43.

Retinol-binding protein 4 correlates with triglycerides but not insulin resistance in prepubertal children with and without premature adrenarche.

Sopher AB, Gerken AT, Lee EJ, Blaner WE, Deeds S, Gallagher D, Shungu DC, Mao X, Hassoun A, Mahon DJ, Oberfield SE.

J Pediatr Endocrinol Metab. 2011;24(9-10):683-7.

44.

Natural history of MELAS associated with mitochondrial DNA m.3243A>G genotype.

Kaufmann P, Engelstad K, Wei Y, Kulikova R, Oskoui M, Sproule DM, Battista V, Koenigsberger DY, Pascual JM, Shanske S, Sano M, Mao X, Hirano M, Shungu DC, Dimauro S, De Vivo DC.

Neurology. 2011 Nov 29;77(22):1965-71. doi: 10.1212/WNL.0b013e31823a0c7f. Epub 2011 Nov 16.

45.

Intracranial dural arteriovenous fistula presenting as an enhancing lesion of the medulla.

Patsalides A, Tzatha E, Stübgen JP, Shungu DC, Stieg PE, Gobin YP.

J Neurointerv Surg. 2010 Dec;2(4):390-3. doi: 10.1136/jnis.2009.001750. Epub 2010 Jun 15.

PMID:
21990654
46.

Anterior cingulate cortex γ-aminobutyric acid in depressed adolescents: relationship to anhedonia.

Gabbay V, Mao X, Klein RG, Ely BA, Babb JS, Panzer AM, Alonso CM, Shungu DC.

Arch Gen Psychiatry. 2012 Feb;69(2):139-49. doi: 10.1001/archgenpsychiatry.2011.131. Epub 2011 Oct 3.

47.

Metabolic syndrome and neurometabolic asymmetry of hippocampus in adult bonnet monkeys.

Coplan JD, Abdallah CG, Mathew SJ, Shungu DC, Mao X, Smith EL, Kaufman D, Gorman JM, Owens MJ, Nemeroff CB, Banerji MA, Rosenblum LA, Kral JG.

Physiol Behav. 2011 Jul 6;103(5):535-9. doi: 10.1016/j.physbeh.2011.03.020. Epub 2011 Apr 1.

48.

Early-life stress, corpus callosum development, hippocampal volumetrics, and anxious behavior in male nonhuman primates.

Jackowski A, Perera TD, Abdallah CG, Garrido G, Tang CY, Martinez J, Mathew SJ, Gorman JM, Rosenblum LA, Smith EL, Dwork AJ, Shungu DC, Kaffman A, Gelernter J, Coplan JD, Kaufman J.

Psychiatry Res. 2011 Apr 30;192(1):37-44. doi: 10.1016/j.pscychresns.2010.11.006. Epub 2011 Mar 5.

49.

Early-life stress and neurometabolites of the hippocampus.

Coplan JD, Mathew SJ, Abdallah CG, Mao X, Kral JG, Smith EL, Rosenblum LA, Perera TD, Dwork AJ, Hof PR, Gorman JM, Shungu DC.

Brain Res. 2010 Oct 28;1358:191-9. doi: 10.1016/j.brainres.2010.08.021. Epub 2010 Aug 14.

50.

Increased ventricular lactate in chronic fatigue syndrome measured by 1H MRS imaging at 3.0 T. II: comparison with major depressive disorder.

Murrough JW, Mao X, Collins KA, Kelly C, Andrade G, Nestadt P, Levine SM, Mathew SJ, Shungu DC.

NMR Biomed. 2010 Jul;23(6):643-50. doi: 10.1002/nbm.1512.

PMID:
20661876

Supplemental Content

Loading ...
Support Center